Stay updated on Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.

Latest updates to the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.6.4 now appears on the page, replacing the previous v3.6.3. This denotes a minor update to the page's revision metadata rather than substantive changes to the study details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision tag was updated to v3.6.3, replacing the previous v3.6.2, signaling a version update to the page or its documents.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded a new 2024 publication citation about long-term safety of gantenerumab (Marguerite RoAD) to the Publications section. Updated the revision tag from v3.6.0 to v3.6.2.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now includes a recruitment status update and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a Revision: v3.6.0 note; the previous text items 'Intervention / Treatment' and 'Revision: v3.5.5' were removed.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This represents a minor update to the page version and does not change any study information.SummaryDifference0.0%

- Check62 days agoChange DetectedNo textual changes were detected for the Study Details page; the content remains unchanged. This indicates the page’s information and structure are the same as before.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.